Monthly Archives: February 2021

MindMed will purchase HealthMode from AI Medicine Company for C $ 42 million – MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF)

[ad_1] MindMed (NEO: MMED) (OTCQB: MMEDF) agreed to buy Health Mode, an artificial intelligence-based medicine company, in a C $ 41.56 million (US $ 32.5 million) stock and cash transaction. The psychedelic biotech company confirmed Thursday that it will acquire a digital medicine and therapeutics start-up that uses digital measurements …

Read More »

Gemini Therapeutics Debut as a Listed Precision Medicine Company Focused on Age-Related Macular Degeneration

[ad_1] CAMBRIDGE, Mass .– (COMMERCIAL THREAD) – Gemini Therapeutics, a clinical-stage precision medicine company that develops innovative treatments for genetically defined age-related macular degeneration (AMD), today announced the completion of its combination with FS Development Corp. (Nasdaq: FSDC), a Specific Purpose Acquisition (SPAC) sponsored by Foresite Capital. Gemini Therapeutics, Inc., …

Read More »